Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Latent class analysis of sexual behaviours and attitudes to sexually transmitted infections among gay and bisexual men using PrEP

Traeger MW, Murphy D, Ryan KE, Asselin J, Cornelisse VJ, Wilkinson AL, Hellard ME, Wright EJ, Stoové MA

(2022), AIDS Behav, 26(6), 1808-20

DOI: 10.1007/s10461-021-03529-w

Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data

Traeger MW, Guy R, Asselin J, Patel P, Carter A, Wright EJ, Grulich A, McManus H, Fairley CK, Chow EPF, McNulty A, Finlayson R, Bell C, Owen L, Marshall L, Russell D, O'Donnell D, Donovan B, Hellard ME, Stoové MA; Australian Collaboration for Coordinated

(2022), Lancet Infect Dis, 22(8), 1231-41

DOI: 10.1016/s1473-3099(22)00175-x

Critical timing and extent of public health interventions to control outbreaks dominated by SARS-CoV-2 variants in Australia: a mathematical modelling study

Zou Z, Fairley CK, Shen M, Scott N, Xu X, Li Z, Li R, Zhuang G, Zhang L

(2022), Int J Infect Dis, 115, 154-65

DOI: 10.1016/j.ijid.2021.11.024

"How PrEPared are you?": Knowledge of and attitudes toward PrEP among overseas-born and newly arrived gay, bisexual, and other men who have sex with men in Australia

Sudarto B, Chow EPF, Medland N, Fairley CK, Wright EJ, Armishaw J, Price B, Phillips TR, Ong JJ

(2022), Front Public Health, 10, 946771

DOI: 10.3389/fpubh.2022.946771

Preferences for HIV Testing Services and HIV Self-Testing Distribution Among Migrant Gay, Bisexual, and Other Men Who Have Sex With Men in Australia

Zhang Y, Wiseman V, Applegate TL, Lourenco RA, Street DJ, Smith K, Jamil MS, Terris-Prestholt F, Fairley CK, McNulty A, Hynes A, Johnson K, Chow EPF, Bavinton BR, Grulich A, Stoové M, Holt M, Kaldor J, Guy R, Ong JJ

(2022), FRONT MED-LAUSANNE, 9, 839479

DOI: 10.3389/fmed.2022.839479

Improved rapid diagnostic tests to detect syphilis and yaws: a systematic review and meta-analysis

Zhang Y, Goh SM, Mello MB, Baggaley RC, Wi T, Johnson CC, Asiedu KB, Marks M, Pham MD, Fairley CK, Chow EPF, Mitjà O, Toskin I, Ballard RC, Ong JJ

(2022), Sex Transm Infect, 98(8), 608-16

DOI: 10.1136/sextrans-2022-055546

Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A

Xu H, Locarnini S, Wong D, Hammond R, Colledge D, Soppe S, Huynh T, Shaw T, Thompson AJ, Revill PA, Hogarth PM, Wines BD, Walsh R, Warner N

(2022), J Hepatol, 76(1), 34-45

DOI: 10.1016/j.jhep.2021.07.031

High effectiveness of broad access direct-acting antiviral therapy for hepatitis C in an Australian real-world cohort: The REACH-C Study

Yee J, Carson JM, Hajarizadeh B, Hanson J, O'Beirne J, Iser D, Read P, Balcomb A, Doyle JS, Davies J, Martinello M, Marks P, Dore GJ, Matthews GV; REACH-C Study Group

(2022), Hepatol Commun, 6(3), 496-512

DOI: 10.1002/hep4.1826

Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2

Wines BD, Kurtovic L, Trist HM, Esparon S, Lopez E, Chappin K, Chan LJ, Mordant FL, Lee WS, Gherardin NA, Patel SK, Hartley GE, Pymm P, Cooney JP, Beeson JG, Godfrey DI, Burrell LM, van Zelm MC, Wheatley AK, Chung AW, Tham WH, Subbarao K, Kent SJ, Hogarth

(2022), Front Immunol, 13, 889372

DOI: 10.3389/fimmu.2022.889372

Hepatitis C incidence among patients attending primary care health services that specialise in the care of people who inject drugs, Victoria, Australia, 2009 to 2020

Wilkinson AL, van Santen DK, Traeger MW, Sacks-Davis R, Asselin J, Scott N, Harney BL, Doyle JS, El-Hayek C, Howell J, Bramwell F, McManus H, Donovan B, Stoové M, Hellard M, Pedrana A

(2022), Int J Drug Policy, 103, 103655

DOI: 10.1016/j.drugpo.2022.103655

Understanding how to live with hepatitis B: a qualitative investigation of peer advice for Chinese people living with hepatitis B in Australia

Wallace J, Xiao Y, Howell J, Thompson A, Allard N, Adamson E, Richmond J, Hajarizadeh B, Eagle M, Doyle J, Hellard M

(2022), BMC Public Health, 22(1), 536

DOI: 10.1186/s12889-022-12907-5

Interventions to eliminate hepatitis C: which ones suit your community?

Wade AJ, Doyle JS

(2022), LANCET GASTROENTEROL, 7(5), 383-4

DOI: 10.1016/s2468-1253(22)00010-3

Does naloxone provision lead to increased substance use? A systematic review to assess if there is evidence of a 'moral hazard' associated with naloxone supply

Tse WC, Djordjevic F, Borja V, Picco L, Lam T, Olsen A, Larney S, Dietze P, Nielsen S

(2022), Int J Drug Policy, 100, 103513

DOI: 10.1016/j.drugpo.2021.103513

Impact of COVID-19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs

Traeger MW, van Santen DK, Sacks-Davis R, Asselin J, Carter A, Doyle JS, Pedrana A, Wilkinson AL, Howell J, Thatcher R, Didlick J, Donovan B, Guy R, Hellard ME, Stoové MA; Australia Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually

(2022), J VIRAL HEPATITIS, 29(10), 908-18

DOI: 10.1111/jvh.13723

Antiretroviral initiation at ≥800 CD4+ cells/ mm 3 associated with lower HIV reservoir size

Rasmussen TA, Ahuja SK, Kuwanda L, Vjecha MJ, Hudson F, Lal L, Rhodes A, Chang J, Palmer S, Auberson-Munderi P, Mugerwa H, Wood R, Badal-Faesen S, Pillay S, Mngqibisa R, LaRosa A, Hildago J, Petoumenos K, Chiu C, Lutaakome J, Kitonsa J, Kabaswaga E, Pala

(2022), Clin Infect Dis, 75(10), 1781-91

DOI: 10.1093/cid/ciac249

Point-of-Care Diagnostics for Diagnosis of Active Syphilis Infection: Needs, Challenges and the Way Forward

Pham MD, Ong JJ, Anderson DA, Drummer HE, Stoové M

(2022), INT J ENV RES PUB HE, 19(13), 8172

DOI: 10.3390/ijerph19138172

A cohort study of differences in trauma outcomes between females and males at four Indian Urban Trauma Centers

Pendleton AA, Sarang B, Mohan M, Raykar N, Wärnberg MG, Khajanchi M, Dharap S, Fitzgerald M, Sharma N, Soni KD, O'Reilly G, Bhandarkar P, Misra M, Mathew J, Jarwani B, Howard T, Gupta A, Cameron P, Bhoi S, Roy N

(2022), Injury, 53(9), 3052-8

DOI: 10.1016/j.injury.2022.07.022

Care navigation increases initiation of hepatitis C treatment after release from prison in a prospective randomized controlled trial: The C-LINK Study

Papaluca T, Craigie A, McDonald L, Edwards A, Winter R, Hoang A, Pappas A, Waldron A, McCoy K, Stoové M, Doyle J, Hellard M, Holmes J, MacIsaac M, Desmond P, Iser D, Thompson AJ

(2022), OPEN FORUM INFECT DI, 9(8), ofac350

DOI: 10.1093/ofid/ofac350

Screening for risky drinkers among hospitalised inpatients using the AUDIT: A feasibility, point prevalence and data linkage study

O'Brien H, Di Rico R, Dean E, Smoker G, Lloyd-Jones M, McKechnie M, Dietze PM, Doyle JS

(2022), Drug Alcohol Rev, 41(1), 293-302

DOI: 10.1111/dar.13343

Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial

McMahon JH, Lau JSY, Coldham A, Roney J, Hagenauer M, Price S, Bryant M, Garlick J, Paterson A, Lee SJ, O'Bryan J, Hearps A, Tachedjian G, Pinskier H, Phillips C, Garrow S, Pinskier N, Melvin R, Blakeway L, Wisniewski JA, Byers S, Badoordeen GZ, Pereira S

(2022), EClinicalMedicine, 54, 101703

DOI: 10.1016/j.eclinm.2022.101703

39 40 41 42 43